Manipal Academy of Higher Education will organise a two-day online international conference on “Ecosophy, art and peace” (ICEAP-2021), from Thursday. Being organised by the Gandhian Centre for Philoso
Experienced biopharma leader to oversee research, candidate development, clinical and regulatory functions
CAMBRIDGE, Mass. (BUSINESS WIRE) Axcella (Nasdaq:AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases and improve health using endogenous metabolic modulator (EMM) compositions, today announced the appointment of Alison D. Schecter, M.D., as the company’s President of Research and Development. In this role, Dr. Schecter will oversee all of the company’s research, product candidate design, clinical and regulatory efforts. Additionally, Manu Chakravarthy, M.D., Ph.D., has decided to step down as the company’s Chief Medical Officer to pursue another opportunity.
Share this article
Share this article
LINKÖPING, Sweden, Jan. 12, 2021 /PRNewswire/ A perspective review article titled Harnessing Muscle-Liver Crosstalk to Treat Nonalcoholic Steatohepatitis was recently published in
Frontiers in Endocrinology as part of a special issue of Non-Alcoholic Steatohepatitis (NASH) Metabolic Contributors and Therapeutic Targets. Authored by scientific experts from Axcella Health, AMRA Medical, Linköping University, and Virginia Commonwealth University (VCU), this paper describes the link between muscle composition and chronic liver diseases, including non-alcoholic fatty liver disease (NAFLD). It discusses in depth the scientific basis of underlying factors outside of the liver to treat NAFLD – affecting nearly one-quarter of the world s adult population.
AXA1665 Phase 2 trial initiation planned for Q2
AXA1125 Phase 2b trial initiation planned for Q2
Company decides not to expand enrollment in AXA4010-001 following cohort 1 readout
Pipeline. | January 16, 2021
Rajinikanth exits as political reality kicks in deccanherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from deccanherald.com Daily Mail and Mail on Sunday newspapers.